National CineMedia completes $275 million Captivate acquisition
National CineMedia (NASDAQ:NCMI) announced the completion of its previously announced acquisition of Captivate Holdings for an enterprise value of $275 million.
Todas as matérias desta seção, das mais recentes às mais antigas — página 51 de 371.
National CineMedia (NASDAQ:NCMI) announced the completion of its previously announced acquisition of Captivate Holdings for an enterprise value of $275 million.
Nuvini Group (NASDAQ:NVNI) reported improved financial performance for the first half of 2026, with operating income reaching R$19.6 million compared with an operating loss of R$32.0 million in the same period last year.
Johnson & Johnson (NYSE:JNJ) announced positive topline results from a pivotal Phase 3 trial evaluating CAPLYTA® (lumateperone) 42 mg once daily for the treatment of acute manic episodes in adults with bipolar I disorder.
JPMorgan's (NYSE:JPM) asset management division and Qatar Investment Authority have signed a Memorandum of Understanding for a strategic investment partnership valued at $20 billion.
ZJK Industrial (NASDAQ:ZJK) reported first-half 2026 financial results, with revenue reaching US$33.74 million for the six months ended June 30, 2026, representing a 36.6% increase compared with the prior-year period.
AbbVie (NYSE:ABBV) announced a multi-year collaboration with Iambic Therapeutics to apply artificial intelligence technologies to discover and develop small molecule therapies.
Magnachip Semiconductor (NYSE:MX) announced that Navitas Semiconductor (NASDAQ:NVTS) will make a $5 million strategic equity investment in the company.
Syntec Optics Holdings (NASDAQ:OPTX) announced an order to supply advanced optical components for U.S. Space Force infrastructure and U.S. National Reconnaissance Office satellite constellations.
Helus Pharma (NASDAQ:HELP) presented four posters on its investigational oral deuterated psilocin analog HLP003 for major depressive disorder (MDD) at Psych Congress 2026 in New Orleans.
Priority Technology Holdings (NASDAQ:PRTH) entered a definitive agreement to be acquired by an investor group led by Chairman and CEO Thomas Priore, which will purchase all outstanding shares it does not already own for $8.05 per share in cash.
Bruker (NASDAQ:BRKR) announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation valued at more than $6 million.
Alkermes (NASDAQ:ALKS) reported positive topline results from a phase 1 proof-of-concept study evaluating ALKS 7290, an investigational orexin 2 receptor agonist being developed for attention-deficit hyperactivity disorder (ADHD).
Kodiak Gas Services (NYSE:KGS) entered an agreement to provide 76 megawatts of behind-the-meter baseload power capacity, including balance of plant services, to a West Texas data center for six years.
Precigen (NASDAQ:PGEN) received U.S. FDA platform technology designation for its AdenoVerse immunotherapeutic platform, which supports the company’s first commercial product, PAPZIMEOS.
Insmed (NASDAQ:INSM) received FDA Priority Review for its supplemental New Drug Application seeking full approval of ARIKAYCE (amikacin liposome inhalation suspension) for treating Mycobacterium avium complex (MAC) lung disease.
Namib Minerals (NASDAQ:NAMM) completed dewatering at its Redwing Mine in Zimbabwe, achieving the first step in its five-step mine restart pathway ahead of its original fourth-quarter 2026 target.
Merck (NYSE:MRK) announced that Japan’s Ministry of Health, Labour and Welfare approved KEYJECT (pembrolizumab and berahyaluronidase alfa-pmph) injection for subcutaneous use across all indications approved for KEYTRUDA in Japan.
Einride (NASDAQ:ENRD) announced a strategic collaboration with NVIDIA (NASDAQ:NVDA) to develop the next generation of its Einride Driver autonomous trucking system.
VinFast Auto (NASDAQ:VFS) began U.S. sales of the 2027 model year VF 8 electric SUV, featuring updated technology, safety systems and driver-assistance features.
Sunshine Silver Mining & Refining (NYSE:SSMR) expanded its consolidated mineral rights in Idaho’s Silver Valley by approximately 14,100 acres, increasing its land position to about 38,000 acres.
Novo Nordisk (NYSE:NVO) reported phase 3 topline results showing once-weekly CagriSema achieved weight loss and blood sugar reductions in adults with type 2 diabetes and obesity.
Ethan Allen Interiors (NYSE:ETD) announced that its Board of Directors has started a formal CEO succession process and expects to name its next chief executive by June 30, 2027.
Vertical Aerospace (NYSE:EVTL) appointed Fabrice Brégier as Chair of its Board of Directors, effective September 21, 2026, as the company advances development of its electric vertical take-off and landing (eVTOL) aircraft.
Ennis (NYSE:EBF) reported revenue of $102 million for the quarter ended August 31, 2026, an increase of $3.3 million, or 3.3%, compared with the same period last year.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade